Dr. Dean Sutherland, MD

NPI: 1346251089
Total Payments
$67,914
2024 Payments
$1,588
Companies
60
Transactions
597
Medicare Patients
8,056
Medicare Billing
$1.4M

Payment Breakdown by Category

Other$49,800 (73.3%)
Food & Beverage$11,743 (17.3%)
Consulting$4,500 (6.6%)
Travel$1,774 (2.6%)
Education$96.75 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,200 43 53.3%
Honoraria $13,600 9 20.0%
Food and Beverage $11,743 532 17.3%
Consulting Fee $4,500 2 6.6%
Travel and Lodging $1,774 9 2.6%
Education $96.75 2 0.1%

Top Paying Companies

Company Total Records Latest Year
US WorldMeds, LLC $15,170 43 $0 (2020)
Amneal Pharmaceuticals LLC $12,875 44 $0 (2024)
Teva Pharmaceuticals USA, Inc. $12,373 44 $0 (2024)
Acorda Therapeutics, Inc $11,714 33 $0 (2024)
Sunovion Pharmaceuticals Inc. $7,234 27 $0 (2021)
ABBVIE INC. $1,569 76 $0 (2024)
UCB, Inc. $695.92 46 $0 (2024)
Allergan, Inc. $591.75 44 $0 (2022)
Neurocrine Biosciences, Inc. $493.61 17 $0 (2024)
Abbott Laboratories $473.04 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,588 53 ABBVIE INC. ($618.70)
2023 $1,522 63 AbbVie Inc. ($396.70)
2022 $5,257 71 Amneal Pharmaceuticals LLC ($3,818)
2021 $11,145 48 Amneal Pharmaceuticals LLC ($4,767)
2020 $17,283 78 Acorda Therapeutics, Inc ($9,071)
2019 $1,588 83 Acorda Therapeutics, Inc ($412.25)
2018 $14,789 113 US WorldMeds, LLC ($7,199)
2017 $14,743 88 US WorldMeds, LLC ($7,893)

All Payment Transactions

597 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/16/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $24.35 General
Category: BOTOX THERAPEUTIC
12/09/2024 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $23.57 General
Category: Musculoskeletal
12/04/2024 UCB, Inc. Zilbrysq (Drug) Food and Beverage In-kind items and services $22.70 General
Category: Neurology
12/02/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $28.57 General
Category: BOTOX THERAPEUTIC
10/31/2024 ABBVIE INC. VYALEV (Drug), DUOPA Food and Beverage In-kind items and services $20.46 General
Category: NEUROSCIENCE
10/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $24.61 General
Category: PAIN
10/29/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $26.82 General
Category: NEUROSCIENCE
10/23/2024 Kyowa Kirin, Inc. Nourianz (Drug) Food and Beverage In-kind items and services $18.74 General
Category: Adenosine A2A Receptors
10/21/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $20.32 General
Category: EPILEPSY
10/15/2024 MITSUBISHI TANABE PHARMA AMERICA, INC. RADICAVA (Drug), RADICAVA ORS Food and Beverage In-kind items and services $34.99 General
Category: AMYOTROPHIC LATERAL SCLEROSIS
10/02/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $34.19 General
Category: Neuropsychiatry
10/01/2024 Amneal Pharmaceuticals LLC ONGENTYS (Drug) Food and Beverage In-kind items and services $15.81 General
Category: NEUROLOGY
09/24/2024 InSightec,Inc Exablate (Device) Food and Beverage Cash or cash equivalent $21.50 General
Category: Neurology
09/23/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA Food and Beverage In-kind items and services $21.80 General
Category: IMMUNOLOGY
09/18/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $12.25 General
Category: NEUROSCIENCE
09/04/2024 CATALYST PHARMACEUTICALS, INC. FIRDAPSE (Drug) Food and Beverage Cash or cash equivalent $37.93 General
Category: NEUROLOGY
09/03/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $33.16 General
Category: Rare Disease
08/28/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $21.82 General
Category: Central Nervous System
08/27/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $33.07 General
Category: Rare Disease
08/27/2024 ABBVIE INC. DUOPA (Drug) Food and Beverage In-kind items and services $18.86 General
Category: NEUROSCIENCE
08/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.07 General
Category: PSYCHIATRY
08/20/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.27 General
Category: NEUROSCIENCE
08/19/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $24.16 General
Category: AESTHETICS AND THERAPEUTICS
08/09/2024 ABBVIE INC. DUOPA (Drug) Food and Beverage In-kind items and services $15.38 General
Category: NEUROSCIENCE
08/05/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $42.47 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 1,949 26,720 $846,256 $360,508
2022 22 1,891 22,009 $764,168 $327,538
2021 22 2,122 24,795 $887,683 $391,121
2020 24 2,094 21,743 $740,291 $322,932
Total Patients
8,056
Total Services
95,267
Medicare Billing
$1.4M
Procedure Codes
89

All Medicare Procedures & Services

89 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 791 1,287 $281,853 $115,235 40.9%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 71 22,792 $227,920 $112,779 49.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 333 384 $57,984 $23,104 39.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 144 173 $50,862 $22,925 45.1%
J0587 Injection, rimabotulinumtoxinb, 100 units Office 2023 18 1,300 $31,200 $12,995 41.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 78 78 $32,838 $12,241 37.3%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Office 2023 24 68 $17,612 $10,322 58.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 78 79 $32,785 $10,094 30.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 74 74 $20,942 $7,166 34.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $20,646 $7,131 34.5%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 19 39 $11,934 $4,828 40.5%
64611 Injection of chemical for paralysis of salivary glands on both sides of mouth Office 2023 19 46 $12,036 $4,670 38.8%
64642 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity Office 2023 20 35 $10,080 $3,974 39.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 47 49 $7,252 $3,067 42.3%
95983 Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional Office 2023 40 74 $7,918 $2,833 35.8%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 30 46 $4,968 $1,697 34.1%
95984 Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional Office 2023 20 47 $4,371 $1,587 36.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 13 16 $3,408 $1,507 44.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 16 16 $3,472 $1,179 33.9%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 20 20 $2,360 $737.94 31.3%
95970 Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator Office 2023 32 35 $3,815 $437.32 11.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 760 1,276 $279,444 $117,787 42.2%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 60 18,701 $187,005 $89,931 48.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 406 472 $71,272 $28,994 40.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 124 146 $42,924 $19,225 44.8%

About Dr. Dean Sutherland, MD

Dr. Dean Sutherland, MD is a Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346251089.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Sutherland, MD has received a total of $67,914 in payments from pharmaceutical and medical device companies, with $1,588 received in 2024. These payments were reported across 597 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,200).

As a Medicare-enrolled provider, Sutherland has provided services to 8,056 Medicare beneficiaries, totaling 95,267 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Sarasota, FL
  • Active Since 08/10/2006
  • Last Updated 03/16/2020
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1346251089

Products in Payments

  • Xadago (Drug) $14,962
  • RYTARY (Drug) $12,886
  • INBRIJA (Drug) $11,668
  • AUSTEDO (Drug) $8,436
  • KYNMOBI (Drug) $7,055
  • SD809-HD (Drug) $3,583
  • BOTOX (Biological) $775.13
  • Neupro (Drug) $580.77
  • INFINITY (Device) $473.04
  • INGREZZA (Drug) $405.79
  • DUOPA (Drug) $371.11
  • GOCOVRI (Drug) $357.91
  • UBRELVY (Drug) $323.03
  • NUPLAZID (Drug) $315.91
  • SOLIRIS (Drug) $196.06
  • Duopa (Drug) $182.12
  • APTIOM (Drug) $178.62
  • QULIPTA (Drug) $177.34
  • AIMOVIG (Biological) $176.53
  • Exablate (Device) $171.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Sarasota